DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
De Paula E, Kavakli K, Mahlangu J , et al, on behalf of 1804 (adept™ 1) Investigators.
Clinical and laboratory results from adeptTM 1, a phase 2 trial investigating the use of recombinant activated FVII analogue in congenital haemophilia patients with inhibitors.
J Thromb Haemost 2012;
10 (1) 81-89
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.